Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy

Thrombosis Journal

Volumn 6, Issue , 2008, Pages

  Srivastava, Ajay ^a   Hudson, Michael ^a   Hamoud, Ihab ^a   Cavalcante, Joao ^a   Pai, Chetan ^a   Kaatz, Scott ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG CONTRAINDICATION; DRUG UTILIZATION; FALLING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PHYSICIAN; PRESCRIPTION; RISK FACTOR; STROKE;

EID: 47749129686     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-6-6     Document Type: Article

References (29)

1. Feinberg WM Blackshear JL Laupacis A Kronmal R Hart RG Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 1995, 155(5):469-473 10.1001/ archinte.155.5.469 7864703
2. Miyasaka Y Barnes ME Gersh BJ Cha SS Bailey KR Abhayaratna WP Seward JB Tsang TS Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 2006, 114(2):119-125 10.1161/ CIRCULATIONAHA.105.595140 16818816
3. Gage BF Waterman AD Shannon W Boechler M Rich MW Radford MJ Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation Jama 2001, 285(22):2864-2870 10.1001/jama.285.22.2864 11401607
4. Wolf PA Abbott RD Kannel WB Atrial fibrillation: A major contributor to stroke in the elderly. The Framingham Study Arch Intern Med 1987, 147(9):1561-1564 10.1001/archinte.147.9.1561 3632164
5. Wolf PA Abbott RD Kannel WB Atrial fibrillation as an independent risk factor for stroke: The Framingham Study Stroke 1991, 22(8):983-988 1866765
6. Hart RG Pearce LA Aguilar MI Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 2007, 146(12):857-867 17577005
7. Darkow T Vanderplas AM Lew KH Kim J Hauch O Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system Curr Med Res Opin 2005, 21(10):1583-1594 10.1185/030079905X61956 16238898
8. Hylek EM D'Antonio J Evans-Molina C Shea C Henault LE Regan S Translating the results of randomized trials into clinical practice: The challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation Stroke 2006, 37(4):1075-1080 10.1161/ 01.STR.0000209239.71702.ce 16527999
9. Waldo AL Becker RC Tapson VF Colgan KJ Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation J Am Coll Cardiol 2005, 46(9):1729-1736 10.1016/ j.jacc.2005.06.077 16256877
10. Go AS Hylek EM Phillips KA Borowsky LH Henault LE Chang Y Selby JV Singer DE Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study Circulation 2000, 102(1):11-13 10880408
11. Go AS Hylek EM Phillips KA Chang Y Henault LE Selby JV Singer DE Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study Jama 2001, 285(18):2370-2375 10.1001/jama.285.18.2370 11343485
12. McCormick D Gurwitz JH Goldberg RJ Becker R Tate JP Elwell A Radford MJ Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting Arch Intern Med 2001, 161(20):2458-2463 10.1001/archinte.161.20.2458 11700158
13. Weisbord SD Whittle J Brooks RC Is warfarin really underused in patients with atrial fibrillation? J Gen Intern Med 2001, 16(11):743-749 1495287 11722687 10.1111/j.1525-1497.2001.10432.x
14. Beyth RJ Antani MR Covinsky KE Miller DG Chren MM Quinn LM Landefeld CS Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med 1996, 11(12):721-728 10.1007/BF02598985 9016418
15. Go AS Hylek EM Borowsky LH Phillips KA Selby JV Singer DE Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study Ann Intern Med 1999, 131(12):927-934 10610643
16. Fihn SD Callahan CM Martin DC McDonell MB Henikoff JG White RH The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics Ann Intern Med 1996, 124(11):970-979 8624064
17. Hart RG Benavente O McBride R Pearce LA Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis Ann Intern Med 1999, 131(7):492-501 10507957
18. Man-Son-Hing M Laupacis A Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation Arch Intern Med 2002, 162(5):541-550 10.1001/ archinte.162.5.541 11871922
19. Garcia Rodriguez LA Hernandez-Diaz S de Abajo FJ Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies Br J Clin Pharmacol 2001, 52(5):563-571 2014603 11736865 10.1046/j.0306-5251.2001.01476.x
20. Wolfe MM Lichtenstein DR Singh G Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs N Engl J Med 1999, 340(24):1888-1899 10.1056/NEJM199906173402407 10369853
21. Piper JM Ray WA Daugherty JR Griffin MR Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs Ann Intern Med 1991, 114(9):735-740 2012355
22. Gage BF van Walraven C Pearce L Hart RG Koudstaal PJ Boode BS Petersen P Selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin Circulation 2004, 110(16):2287-2292 10.1161/01.CIR.0000145172.55640.93 15477396
23. Fang MC Chang Y Hylek EM Rosand J Greenberg SM Go AS Singer DE Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation Ann Intern Med 2004, 141(10):745-752 15545674
24. Gage BF Birman-Deych E Kerzner R Radford MJ Nilasena DS Rich MW Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall Am J Med 2005, 118(6):612-617 10.1016/ j.amjmed.2005.02.022 15922692
25. Mant J HR Fitzmaurice D et al A randomised controlled trial of warfarin versus aspirin for stroke prevention in atrial fibrillation in a primary care population aged over 75 16th European Stroke Conference 2007.
26. Man-Son-Hing M Nichol G Lau A Laupacis A Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls Arch Intern Med 1999, 159(7):677-685 10.1001/archinte.159.7.677 10218746
27. Fang MC Go AS Hylek EM Chang Y Henault LE Jensvold NG Singer DE Age and the risk of warfarin-associated hemorrhage: The anticoagulation and risk factors in atrial fibrillation study J Am Geriatr Soc 2006, 54(8):1231-1236 10.1111/j.1532-5415.2006.00828.x 16913990
28. Hylek EM Evans-Molina C Shea C Henault LE Regan S Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 2007, 115(21):2689-2696 10.1161/CIRCULATIONAHA.106.653048 17515465
29. Jacobs LG Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly Clin Geriatr Med 2006, 22(1):17-32, vii-viii 10.1016/j.cger.2005.09.001 16377465